Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
48
PMDKF Quote, Financials, Valuation and Earnings
Last price:
$0.0527
Seasonality move
:
6.26%
Day range:
$0.0527 - $0.0527
52-week range:
$0.0527 - $0.1041
Dividend yield:
1.14%
P/E ratio:
7.75x
P/S ratio:
0.35x
P/B ratio:
1.11x
Volume:
--
Avg. volume:
--
1-year change:
-49.38%
Market cap:
$874.8M
Revenue:
$2.4B
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PMDKF
PT Mitra Adiperkasa Tbk
|
-- | -- | -- | -- | -- |
|
ACEHF
PT Aspirasi Hidup Indonesia Tbk
|
-- | -- | -- | -- | -- |
|
BKLPF
PT Bukalapak.com Tbk
|
-- | -- | -- | -- | -- |
|
NUTR
Nutraceutical International Corp.
|
-- | -- | -- | -- | -- |
|
PAKTY
PT MAP Aktif Adiperkasa Tbk
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PMDKF
PT Mitra Adiperkasa Tbk
|
$0.0527 | -- | $874.8M | 7.75x | $0.00 | 1.14% | 0.35x |
|
ACEHF
PT Aspirasi Hidup Indonesia Tbk
|
$0.0035 | -- | $60M | 1.21x | $0.00 | 60% | 0.11x |
|
BKLPF
PT Bukalapak.com Tbk
|
$0.0008 | -- | $82.5M | 0.62x | $0.00 | 0% | 0.23x |
|
NUTR
Nutraceutical International Corp.
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
PAKTY
PT MAP Aktif Adiperkasa Tbk
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PMDKF
PT Mitra Adiperkasa Tbk
|
37.15% | 1.204 | 44.06% | 0.45x |
|
ACEHF
PT Aspirasi Hidup Indonesia Tbk
|
13.69% | -13.705 | 94.64% | 3.24x |
|
BKLPF
PT Bukalapak.com Tbk
|
0.45% | 0.000 | 8.29% | 31.51x |
|
NUTR
Nutraceutical International Corp.
|
-- | 0.000 | -- | -- |
|
PAKTY
PT MAP Aktif Adiperkasa Tbk
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PMDKF
PT Mitra Adiperkasa Tbk
|
$214.7M | $52.8M | 9.53% | 14.71% | 8.25% | $93.7M |
|
ACEHF
PT Aspirasi Hidup Indonesia Tbk
|
$53.1M | $11.3M | 10.77% | 12.38% | 8.94% | $26.2M |
|
BKLPF
PT Bukalapak.com Tbk
|
$5.3M | -$1.6M | 7.82% | 7.84% | -1.61% | $6.8M |
|
NUTR
Nutraceutical International Corp.
|
-- | -- | -- | -- | -- | -- |
|
PAKTY
PT MAP Aktif Adiperkasa Tbk
|
-- | -- | -- | -- | -- | -- |
PT Mitra Adiperkasa Tbk vs. Competitors
-
Which has Higher Returns PMDKF or ACEHF?
PT Aspirasi Hidup Indonesia Tbk has a net margin of 5.32% compared to PT Mitra Adiperkasa Tbk's net margin of 9.07%. PT Mitra Adiperkasa Tbk's return on equity of 14.71% beat PT Aspirasi Hidup Indonesia Tbk's return on equity of 12.38%.
Company Gross Margin Earnings Per Share Invested Capital PMDKFPT Mitra Adiperkasa Tbk33.54% $0.00 $1.4B ACEHFPT Aspirasi Hidup Indonesia Tbk42.09% $0.00 $447.5M -
What do Analysts Say About PMDKF or ACEHF?
PT Mitra Adiperkasa Tbk has a consensus price target of --, signalling downside risk potential of --. On the other hand PT Aspirasi Hidup Indonesia Tbk has an analysts' consensus of -- which suggests that it could fall by --. Given that PT Mitra Adiperkasa Tbk has higher upside potential than PT Aspirasi Hidup Indonesia Tbk, analysts believe PT Mitra Adiperkasa Tbk is more attractive than PT Aspirasi Hidup Indonesia Tbk.
Company Buy Ratings Hold Ratings Sell Ratings PMDKFPT Mitra Adiperkasa Tbk0 0 0 ACEHFPT Aspirasi Hidup Indonesia Tbk0 0 0 -
Is PMDKF or ACEHF More Risky?
PT Mitra Adiperkasa Tbk has a beta of 2.012, which suggesting that the stock is 101.249% more volatile than S&P 500. In comparison PT Aspirasi Hidup Indonesia Tbk has a beta of -1.579, suggesting its less volatile than the S&P 500 by 257.948%.
-
Which is a Better Dividend Stock PMDKF or ACEHF?
PT Mitra Adiperkasa Tbk has a quarterly dividend of $0.00 per share corresponding to a yield of 1.14%. PT Aspirasi Hidup Indonesia Tbk offers a yield of 60% to investors and pays a quarterly dividend of $0.00 per share. PT Mitra Adiperkasa Tbk pays 9.42% of its earnings as a dividend. PT Aspirasi Hidup Indonesia Tbk pays out 64.78% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PMDKF or ACEHF?
PT Mitra Adiperkasa Tbk quarterly revenues are $640.2M, which are larger than PT Aspirasi Hidup Indonesia Tbk quarterly revenues of $126.2M. PT Mitra Adiperkasa Tbk's net income of $34.1M is higher than PT Aspirasi Hidup Indonesia Tbk's net income of $11.4M. Notably, PT Mitra Adiperkasa Tbk's price-to-earnings ratio is 7.75x while PT Aspirasi Hidup Indonesia Tbk's PE ratio is 1.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PT Mitra Adiperkasa Tbk is 0.35x versus 0.11x for PT Aspirasi Hidup Indonesia Tbk. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMDKFPT Mitra Adiperkasa Tbk0.35x 7.75x $640.2M $34.1M ACEHFPT Aspirasi Hidup Indonesia Tbk0.11x 1.21x $126.2M $11.4M
-
Which has Higher Returns PMDKF or BKLPF?
PT Bukalapak.com Tbk has a net margin of 5.32% compared to PT Mitra Adiperkasa Tbk's net margin of 21.79%. PT Mitra Adiperkasa Tbk's return on equity of 14.71% beat PT Bukalapak.com Tbk's return on equity of 7.84%.
Company Gross Margin Earnings Per Share Invested Capital PMDKFPT Mitra Adiperkasa Tbk33.54% $0.00 $1.4B BKLPFPT Bukalapak.com Tbk5.27% $0.00 $1.5B -
What do Analysts Say About PMDKF or BKLPF?
PT Mitra Adiperkasa Tbk has a consensus price target of --, signalling downside risk potential of --. On the other hand PT Bukalapak.com Tbk has an analysts' consensus of -- which suggests that it could fall by --. Given that PT Mitra Adiperkasa Tbk has higher upside potential than PT Bukalapak.com Tbk, analysts believe PT Mitra Adiperkasa Tbk is more attractive than PT Bukalapak.com Tbk.
Company Buy Ratings Hold Ratings Sell Ratings PMDKFPT Mitra Adiperkasa Tbk0 0 0 BKLPFPT Bukalapak.com Tbk0 0 0 -
Is PMDKF or BKLPF More Risky?
PT Mitra Adiperkasa Tbk has a beta of 2.012, which suggesting that the stock is 101.249% more volatile than S&P 500. In comparison PT Bukalapak.com Tbk has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PMDKF or BKLPF?
PT Mitra Adiperkasa Tbk has a quarterly dividend of $0.00 per share corresponding to a yield of 1.14%. PT Bukalapak.com Tbk offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PT Mitra Adiperkasa Tbk pays 9.42% of its earnings as a dividend. PT Bukalapak.com Tbk pays out -- of its earnings as a dividend. PT Mitra Adiperkasa Tbk's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PMDKF or BKLPF?
PT Mitra Adiperkasa Tbk quarterly revenues are $640.2M, which are larger than PT Bukalapak.com Tbk quarterly revenues of $100.2M. PT Mitra Adiperkasa Tbk's net income of $34.1M is lower than PT Bukalapak.com Tbk's net income of $149.5M. Notably, PT Mitra Adiperkasa Tbk's price-to-earnings ratio is 7.75x while PT Bukalapak.com Tbk's PE ratio is 0.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PT Mitra Adiperkasa Tbk is 0.35x versus 0.23x for PT Bukalapak.com Tbk. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMDKFPT Mitra Adiperkasa Tbk0.35x 7.75x $640.2M $34.1M BKLPFPT Bukalapak.com Tbk0.23x 0.62x $100.2M $149.5M
-
Which has Higher Returns PMDKF or NUTR?
Nutraceutical International Corp. has a net margin of 5.32% compared to PT Mitra Adiperkasa Tbk's net margin of --. PT Mitra Adiperkasa Tbk's return on equity of 14.71% beat Nutraceutical International Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PMDKFPT Mitra Adiperkasa Tbk33.54% $0.00 $1.4B NUTRNutraceutical International Corp.-- -- -- -
What do Analysts Say About PMDKF or NUTR?
PT Mitra Adiperkasa Tbk has a consensus price target of --, signalling downside risk potential of --. On the other hand Nutraceutical International Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that PT Mitra Adiperkasa Tbk has higher upside potential than Nutraceutical International Corp., analysts believe PT Mitra Adiperkasa Tbk is more attractive than Nutraceutical International Corp..
Company Buy Ratings Hold Ratings Sell Ratings PMDKFPT Mitra Adiperkasa Tbk0 0 0 NUTRNutraceutical International Corp.0 0 0 -
Is PMDKF or NUTR More Risky?
PT Mitra Adiperkasa Tbk has a beta of 2.012, which suggesting that the stock is 101.249% more volatile than S&P 500. In comparison Nutraceutical International Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PMDKF or NUTR?
PT Mitra Adiperkasa Tbk has a quarterly dividend of $0.00 per share corresponding to a yield of 1.14%. Nutraceutical International Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PT Mitra Adiperkasa Tbk pays 9.42% of its earnings as a dividend. Nutraceutical International Corp. pays out -- of its earnings as a dividend. PT Mitra Adiperkasa Tbk's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PMDKF or NUTR?
PT Mitra Adiperkasa Tbk quarterly revenues are $640.2M, which are larger than Nutraceutical International Corp. quarterly revenues of --. PT Mitra Adiperkasa Tbk's net income of $34.1M is higher than Nutraceutical International Corp.'s net income of --. Notably, PT Mitra Adiperkasa Tbk's price-to-earnings ratio is 7.75x while Nutraceutical International Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PT Mitra Adiperkasa Tbk is 0.35x versus -- for Nutraceutical International Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMDKFPT Mitra Adiperkasa Tbk0.35x 7.75x $640.2M $34.1M NUTRNutraceutical International Corp.-- -- -- --
-
Which has Higher Returns PMDKF or PAKTY?
PT MAP Aktif Adiperkasa Tbk has a net margin of 5.32% compared to PT Mitra Adiperkasa Tbk's net margin of --. PT Mitra Adiperkasa Tbk's return on equity of 14.71% beat PT MAP Aktif Adiperkasa Tbk's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PMDKFPT Mitra Adiperkasa Tbk33.54% $0.00 $1.4B PAKTYPT MAP Aktif Adiperkasa Tbk-- -- -- -
What do Analysts Say About PMDKF or PAKTY?
PT Mitra Adiperkasa Tbk has a consensus price target of --, signalling downside risk potential of --. On the other hand PT MAP Aktif Adiperkasa Tbk has an analysts' consensus of -- which suggests that it could fall by --. Given that PT Mitra Adiperkasa Tbk has higher upside potential than PT MAP Aktif Adiperkasa Tbk, analysts believe PT Mitra Adiperkasa Tbk is more attractive than PT MAP Aktif Adiperkasa Tbk.
Company Buy Ratings Hold Ratings Sell Ratings PMDKFPT Mitra Adiperkasa Tbk0 0 0 PAKTYPT MAP Aktif Adiperkasa Tbk0 0 0 -
Is PMDKF or PAKTY More Risky?
PT Mitra Adiperkasa Tbk has a beta of 2.012, which suggesting that the stock is 101.249% more volatile than S&P 500. In comparison PT MAP Aktif Adiperkasa Tbk has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PMDKF or PAKTY?
PT Mitra Adiperkasa Tbk has a quarterly dividend of $0.00 per share corresponding to a yield of 1.14%. PT MAP Aktif Adiperkasa Tbk offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PT Mitra Adiperkasa Tbk pays 9.42% of its earnings as a dividend. PT MAP Aktif Adiperkasa Tbk pays out -- of its earnings as a dividend. PT Mitra Adiperkasa Tbk's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PMDKF or PAKTY?
PT Mitra Adiperkasa Tbk quarterly revenues are $640.2M, which are larger than PT MAP Aktif Adiperkasa Tbk quarterly revenues of --. PT Mitra Adiperkasa Tbk's net income of $34.1M is higher than PT MAP Aktif Adiperkasa Tbk's net income of --. Notably, PT Mitra Adiperkasa Tbk's price-to-earnings ratio is 7.75x while PT MAP Aktif Adiperkasa Tbk's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PT Mitra Adiperkasa Tbk is 0.35x versus -- for PT MAP Aktif Adiperkasa Tbk. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMDKFPT Mitra Adiperkasa Tbk0.35x 7.75x $640.2M $34.1M PAKTYPT MAP Aktif Adiperkasa Tbk-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
